BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wijarnpreecha K, Ungprasert P, Panjawatanan P, Harnois DM, Zaver HB, Ahmed A, Kim D. COVID-19 and liver injury: a meta-analysis. Eur J Gastroenterol Hepatol. 2021;33:990-995. [PMID: 32639420 DOI: 10.1097/meg.0000000000001817] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Al-Nimer MS. Is COVID-19-induced liver injury different from other RNA viruses?‎ World J Meta-Anal 2021; 9(2): 108-127 [DOI: 10.13105/wjma.v9.i2.108] [Reference Citation Analysis]
2 Kumar D, Srivastava S, Rajnikant T, Dawra S, Tevatia M, Mukherjee R. Liver function tests in COVID 19: A retrospective record-based study from a tertiary care centre in urban Maharashtra, India. Medical Journal Armed Forces India 2022. [DOI: 10.1016/j.mjafi.2022.02.010] [Reference Citation Analysis]
3 Sima AR. Hydroxychloroquine's Probable Protective Effect in Liver injury among the COVID-19 Patients. Middle East J Dig Dis 2021;13:80-1. [PMID: 34712444 DOI: 10.34172/mejdd.2021.209] [Reference Citation Analysis]
4 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021; 9(27): 7998-8007 [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
5 Hashem WM, Abdelaziz H, Sallam DE, Ismail MA, Ahmed AE. Impact of COVID-19 on digestive system: prevalence, clinical characteristics, outcome, and relation to the severity of COVID-19. Egypt J Intern Med 2022;34. [DOI: 10.1186/s43162-022-00132-w] [Reference Citation Analysis]
6 Su YJ, Chang CW, Chen MJ, Lai YC. Impact of COVID-19 on liver. World J Clin Cases 2021;9:7998-8007. [PMID: 34621856 DOI: 10.12998/wjcc.v9.i27.7998] [Reference Citation Analysis]
7 Fu L, Fei J, Xu S, Xiang HX, Xiang Y, Hu B, Li MD, Liu FF, Li Y, Li XY, Zhao H, Xu DX. Liver Dysfunction and Its Association with the Risk of Death in COVID-19 Patients: A Prospective Cohort Study. J Clin Transl Hepatol. 2020;8:246-254. [PMID: 33083246 DOI: 10.14218/jcth.2020.00043] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
8 Shousha HI, Ramadan A, Lithy R, El-Kassas M. Patterns of liver profile disturbance in patients with COVID-19 . World J Clin Cases 2022; 10(7): 2063-2071 [DOI: 10.12998/wjcc.v10.i7.2063] [Reference Citation Analysis]
9 Shousha HI, Afify S, Maher R, Asem N, Fouad E, Mostafa EF, Medhat MA, Abdalazeem A, Elmorsy H, Aziz MM, Mohammed RS, Ibrahem M, Elgarem H, Omran D, Hassany M, Elsayed B, Abdelaziz AY, El Kassas M. Hepatic and gastrointestinal disturbances in Egyptian patients infected with coronavirus disease 2019: A multicentre cohort study. World J Gastroenterol 2021; 27(40): 6951-6966 [PMID: 34790017 DOI: 10.3748/wjg.v27.i40.6951] [Reference Citation Analysis]
10 Di Sessa A, Lanzaro F, Zarrilli S, Picone V, Guarino S, Miraglia del Giudice E, Marzuillo P. COVID-19 and pediatric fatty liver disease: Is there interplay? World J Gastroenterol 2021; 27(22): 3064-3072 [PMID: 34168408 DOI: 10.3748/wjg.v27.i22.3064] [Reference Citation Analysis]
11 Gracia-Ramos AE, Jaquez-Quintana JO, Contreras-Omaña R, Auron M. Liver dysfunction and SARS-CoV-2 infection. World J Gastroenterol 2021; 27(26): 3951-3970 [PMID: 34326607 DOI: 10.3748/wjg.v27.i26.3951] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
12 Gauchel N, Rieder M, Krauel K, Goller I, Jeserich M, Salzer U, Venhoff AC, Baldus N, Pollmeier L, Wirth L, Kern W, Rieg S, Busch HJ, Hofmann M, Bode C, Duerschmied D, Lother A, Heger LA. Complement system component dysregulation is a distinctive feature of COVID-19 disease: a prospective and comparative analysis of patients admitted to the emergency department for suspected COVID-19 disease. J Thromb Thrombolysis 2021. [PMID: 34904186 DOI: 10.1007/s11239-021-02617-x] [Reference Citation Analysis]
13 Ivashkin V, Fomin V, Moiseev S, Brovko M, Maslennikov R, Ulyanin A, Sholomova V, Vasilyeva M, Trush E, Shifrin O, Poluektova E. Efficacy of a Probiotic Consisting of Lacticaseibacillus rhamnosus PDV 1705, Bifidobacterium bifidum PDV 0903, Bifidobacterium longum subsp. infantis PDV 1911, and Bifidobacterium longum subsp. longum PDV 2301 in the Treatment of Hospitalized Patients with COVID-19: a Randomized Controlled Trial. Probiotics Antimicrob Proteins 2021. [PMID: 34643888 DOI: 10.1007/s12602-021-09858-5] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Taneva G, Dimitrov D, Velikova T. Liver dysfunction as a cytokine storm manifestation and prognostic factor for severe COVID-19. World J Hepatol 2021; 13(12): 2005-2012 [DOI: 10.4254/wjh.v13.i12.2005] [Reference Citation Analysis]
15 Briguglio M, Crespi T, Pino F, Mazzocchi M, Porta M, De Vecchi E, Banfi G, Perazzo P. Clinical Characteristics of Severe COVID-19 Patients Admitted to an Intensive Care Unit in Lombardy During the Italian Pandemic. Front Med (Lausanne) 2021;8:582896. [PMID: 33842494 DOI: 10.3389/fmed.2021.582896] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]